MH
Matthew D. Hellmann is a medical oncologist whose research focuses on cancer immunotherapy, particularly immune checkpoint inhibitors for lung cancer and other solid tumors. He has been involved in clinical trials evaluating novel immunotherapeutic approaches.
- Field
- Medicine · Oncology
- Clarivate categories
- Clinical Medicine
- Affiliation
- Memorial Sloan Kettering Cancer Center, United States